Anti-CD22-SAP human [IT-37, KIT-37]

a tool for eliminating cells that possess the group-A epitope of the human B-cell antigen, CD22 in human; targeted via a mouse monoclonal antibody to Human CD22, eliminated via saporin

SKU: IT-37 Category: Quantity: Individual 25 ug, Individual 100 ug, Individual 250 ug, Individual 1 mg, Kit w/controls 25 ug, Kit w/controls 100 ug, Kit w/controls 250 ug | Antibody Type: Monoclonal | Host: mouse | Reactivity: human | Conjugate: saporin | Usage: eliminates cells, retrograde transport |

CD22 is characterized as a doublet of 130/140 kDa and is expressed on the surface of normal human B-cells and some neoplastic B-cell lines and tumors. CD22 has also been further divided into four different epitope groups, A, B, C, and D, which represent groups of determinants situated on different portions of the CD22 molecule. Anti-CD22-SAP recognizes and specifically eliminates cells that possess the group-A epitope of the human B-cell antigen, CD22. Anti-CD22 immunotoxins have been used to study precursor-B cell acute lymphoblastic leukemia.

Anti-CD22-SAP is a chemical conjugate of a mouse monoclonal antibody to Human CD22 and the ribosome-inactivating protein, saporin. It specifically eliminates cells that express the group-A epitope of the human B-cell antigen, CD22.

Anti-CD22-SAP is available individually (Cat. #IT-37) or as a kit (Cat. #KIT-37) which includes Anti-CD22-SAP and Mouse IgG-SAP (Cat. #IT-18).

keywords: CD22, human B cells, UV22-2, B-cell, Anti-CD22, acute, lymphoblastic, leukemia, saporin, targeting, immunotoxin

Reviews

There are no reviews yet.

Be the first to review “Anti-CD22-SAP human [IT-37, KIT-37]”

View Data Sheet

The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies.

Li JL, Shen GL, Ghetie MA, May RD, Till M, Ghetie V, Uhr JW, Janossy G, Thorpe PE, Amlot P, Vitetta ES (1989) The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies. Cell Immunol 118(1):85-99. doi: 10.1016/0008-8749(89)90359-6 PMID: 2463099

Related Products: CD22 Mouse Monoclonal (Cat. #AB-36), Anti-CD22-SAP human (Cat. #IT-37)

Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas.

Shen GL, Li JL, Ghetie MA, Ghetie V, May RD, Till M, Brown AN, Relf M, Knowles P, Uhr JW, Janossy G, Amlot P, Vitetta ES, Thorpe PE (1988) Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas. Int J Cancer 42(5):792-797. doi: 10.1002/ijc.2910420527 PMID: 3263328

Related Products: CD22 Mouse Monoclonal (Cat. #AB-36), Anti-CD22-SAP human (Cat. #IT-37)

browse all references for this product | back to top

Mouse IgG-SAP (Cat. #IT-18)

CD22 Products:

CD22 Mouse Monoclonal (Cat. #AB-36)

Anti-CD22-SAP human (Cat. #IT-37)

Targeting Tools: Targeting B-Cell Leukemias and Lymphomas

Cytotoxicity Assay for Targeted Toxins in vitro

Concentration Calculation Explained: Convert molarity to mg/ml and mg/ml to molarity

Preparing and Interpreting Cytotoxicity Data in vitro


browse all protocols and calculators | back to top

Shopping Cart
Scroll to Top